Cervical CarcinomaNCT06284447
Barriers to Cervical Cancer Screening
An observational study of Cervical Carcinoma, run by Mayo Clinic at 1 site in United States.
Trial summary
This study evaluates barriers to cervical cancer screening among non-compliant women. Read more about this study
- Who is it for?
- Ages 21 to 65 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Cervical Carcinoma
- What is being tested?
- Non-Interventional Study
- How many people
- 2,216 participants
- Where
- 1 siteUnited States
- Study dates
- 23 Mar 2023to 28 Oct 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 65 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: Women aged 21-65 that are non-compliant for cervical cancer screening within the Mayo Clinic Health System
Who may be able to join
- Women between the ages of 21-65
- Non-compliant for cervical cancer screening within Mayo Clinic Primary Care
Who cannot join
- Women less than 21 or older than 65
- Complaint for cervical cancer screening within Mayo Clinic Primary Care
- Women who decline participation
Trial locations and contacts
1 site in 1 country.
United States1 site
Mayo Clinic in Rochester
Rochester, Minnesota, 55905
About this study
This study evaluates barriers to cervical cancer screening among non-compliant women.
Read the detailed description
PRIMARY OBJECTIVE:
- To further identify barriers to cervical cancer screening in women, we will identify non-compliant patients and survey them to better understand barriers that have led to inadequate screening.
OUTLINE: This is an observational study.
Participants complete a survey on study.
- Conditions
- Cervical Carcinoma
- Being tested
- Non-Interventional Study
- Medical subject headings
- Uterine Cervical Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Non-Interventional StudyOther
Non interventional study
| Study group | Role | What they receive |
|---|---|---|
| Observational | Participants complete a survey on study. Receives: Other: Non-Interventional Study |
What is being measured
The primary outcome is the main question the study is designed to answer.
Identify barriers to cervical cancer screening
Participants will receive a brief "Pap Smear Barriers Survey" (likely completed in 5-15 minutes) which asks yes/no/no preference questions regarding potential barriers to cervical cancer screening. Responses will be compared regionally and by Mayo Clinic Health System site.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Feb 2024
- Study start23 Mar 2023
- Primary completion28 Oct 2023
- Study completion28 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cervical CarcinomaStudies of the same condition, open and under way.
- More trials run by Mayo ClinicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 2,216 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Brittany A. Strelow, DSMc, PA-C, Principal investigator, Mayo Clinic in Rochester
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06284447
- Sponsor's protocol ID
- 22-004500
- Other IDs
- NCI-2024-00181, 22-004500
- Status last verified
- May 2025
- First submitted
- 22 Feb 2024
- Last updated
- 21 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Barriers to Cervical Cancer Screening
- ClinicalTrials.gov ID
- NCT06284447
- Acronym / sponsor ID
- 22-004500
- Conditions
- Cervical Carcinoma
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,216 participants (actual)
- Lead sponsor
- Mayo ClinicUniversity, hospital or other
- Study start
- 23 Mar 2023 (actual)
- Primary completion
- 28 Oct 2023 (actual)
- Study completion
- 28 Oct 2023 (actual)
- First posted
- 29 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates barriers to cervical cancer screening among non-compliant women.
Detailed description
PRIMARY OBJECTIVE:
- To further identify barriers to cervical cancer screening in women, we will identify non-compliant patients and survey them to better understand barriers that have led to inadequate screening.
OUTLINE: This is an observational study.
Participants complete a survey on study.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Observational | – | Other: Non-Interventional StudyParticipants complete a survey on study. |
Who may qualify
- Ages
- 21 to 65 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Women aged 21-65 that are non-compliant for cervical cancer screening within the Mayo Clinic Health System
Key inclusion criteria (2 listed)
- Women between the ages of 21-65
- Non-compliant for cervical cancer screening within Mayo Clinic Primary Care
Key exclusion criteria (3 listed)
- Women less than 21 or older than 65
- Complaint for cervical cancer screening within Mayo Clinic Primary Care
- Women who decline participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Non-Interventional StudyNon interventional study | Other | Observational |
Primary outcome
Identify barriers to cervical cancer screening
Time frame: Baseline
Participants will receive a brief "Pap Smear Barriers Survey" (likely completed in 5-15 minutes) which asks yes/no/no preference questions regarding potential barriers to cervical cancer screening. Responses will be compared regionally and by Mayo Clinic Health System site.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 May 2025.
- Mayo Clinic Clinical TrialsLink provided by the sponsor.
Related trials for Cervical Carcinoma
RecruitingPhase 1/2
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Advanced/Metastatic Solid Tumors, Colorectal Cancer
Recruiting
The Effectiveness of Structured Swallowing Exercise Therapy in Patients With Nasopharyngeal Carcinoma: An Assessment of Swallowing Function and Quality of Life
Nasopharyngeal Carcinoma (NPC)
Active, not recruiting
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection
Esophageal Squamous Cell Carcinoma (ESCC), High-Grade Intraepithelial Neoplasia
Active, not recruitingPhase 3
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Head and Neck Squamous Cell Carcinoma
RecruitingPhase 2
Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
Metastatic Cancer, Cervical Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Brittany A. Strelow, DSMc, PA-C principal investigator
Mayo Clinic in Rochester
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cervical Carcinoma, run by Mayo Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Identify barriers to cervical cancer screening (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2025.